Cenobamate as add‐on treatment for SCN8A developmental and epileptic encephalopathy

Documenti analoghi

• Fenfluramine treatment in pediatric patients with Dravet syndrome reduces seizure burden and overall healthcare costs: A retrospective and observational real‐world study
  di: Cathrine E. Gjerulfsen, et al.
  Pubblicazione: (2024)
• The epilepsy–autism phenotype associated with developmental and epileptic encephalopathies: New mechanism‐based therapeutic options
  di: Nicola Specchio, et al.
  Pubblicazione: (2025)
• Developmental and epileptic encephalopathy with spike–wave activation in sleep: From the ‘functional ablation’ model to a neurodevelopmental network perspective
  di: Luca Andreoli, et al.
  Pubblicazione: (2025)
• Differential outcomes in familial and sporadic SCN8A self‐limited infantile epilepsies: Insights from a large international registry
  di: Francesca Furia, et al.
  Pubblicazione: (2025)
• Developmental and/or epileptic encephalopathy with spike‐and‐wave activation in sleep: Pathophysiological insights and treatment options
  di: Nicola Specchio, et al.
  Pubblicazione: (2026)